PROVENGE, an autologous cellular immunotherapy used as a treatment for asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer (CRPC). Visit www.provengehcp.com
PROVENGE, an autologous cellular immunotherapy used as a treatment for asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer (CRPC). Visit www.provengehcp.com
Register for the PROVENGE Jumpstart Program. Find information and support in your battle against advanced prostate cancer, visit Provenge.com for more.
[hana-flv-player][hana-flv-player video="http://brucehaytonmd.com/hayton1.flv" player="4" more_4="plugins: { controls: true } "/] Dr. Bruce Hayton is Board Certified in Medical Oncology and Internal Medicine who provides adva
[hana-flv-player][hana-flv-player video="http://brucehaytonmd.com/hayton1.flv" player="4" more_4="plugins: { controls: true } "/] Dr. Bruce Hayton is Board Certified in Medical Oncology and Internal Medicine who provides adva
[hana-flv-player][hana-flv-player video="http://brucehaytonmd.com/hayton1.flv" player="4" more_4="plugins: { controls: true } "/] Dr. Bruce Hayton is Board Certified in Medical Oncology and Internal Medicine who provides adva
[hana-flv-player][hana-flv-player video="http://brucehaytonmd.com/hayton1.flv" player="4" more_4="plugins: { controls: true } "/] Dr. Bruce Hayton is Board Certified in Medical Oncology and Internal Medicine who provides adva
Dedicated to helping persons who face cancer. Supports research, patient services, early detection, treatment and education. Contact us anytime day or night 1-800-227-234.